The effect of pubertal delay by GnRH agonist in gh-deficient children on final height

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 10, 2001, Pages 4655-4656

  Mul, D ^a   Wit, J M ^b   Oostdijk, W ^b   Van Den Broeck, J ^c  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Dutch Growth Research Foundation   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN AGONIST; GROWTH HORMONE; LEUPRORELIN; TRIPTORELIN;

ARTICLE; BODY HEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DELAYED PUBERTY; DRUG EFFICACY; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONAL THERAPY; HUMAN; MALE; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT OUTCOME;

EID: 0034749983     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.86.10.7910     Document Type: Article

References (6)

1. Management of puberty in growth hormone deficient children
2. Near final height in pubertal growth hormone (GH)-deficient patients treated with GH alone or in combination with luteinizing hormone-releasing hormone analog: Results of a prospective, randomized trial
3. Growth diagrams 1980. Netherlands third nation-wide survey
4. Adult height in 24 patients treated for growth hormone deficiency and early puberty
5. The influence of gonadal function and the effect of gonadal suppression treatment on final height in growth hormone (GH)-treated GH-deficient children
6. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone